Skip to main content
IBB logo
IBB
(NASDAQ)
iShares Biotechnology ETF
$165.93-- (--)
Loading... - Market loading

IBB ETF: iShares Biotechnology ETF - Price, Holdings & Analysis

iShares Biotechnology ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$168.89 - $172.44
52-Week High$179.64
52-Week Low$123.61
Open$169.35
Volume1.45M
Average Volume (3M)1.45M
Assets (AUM)8.48B
Expense Ratio0.44%
Total Holdings257
Inception DateFeb 4, 2001
1 Day Change1.97%
1 Month Change-1.56%
6 Month Change-2.68%
YTD Change-0.89%
1 Year Change33.87%
52-Week Change34.18%
5 Year Change9.46%
10 Year Change78.34%
50-Day MA$169.58
200-Day MA$163.41
RSI46.69
Stochastic %K47.88
Stochastic %D43.88
Annual Dividend$0.39
Dividend Yield0.23%
Last Dividend Ex-DateMar 17, 2026
Dividend Growth YoY1.31%

Frequently Asked Questions About iShares Biotechnology ETF

What is the current price of IBB?

The latest IBB price is $171.43. The 52-week range is $123.61–$179.64. IBB has returned 34.2% over the past 52 weeks.

What is the expense ratio for IBB?

IBB's annual expense ratio is 0.44%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.

Does IBB pay dividends?

Yes, IBB pays a 0.23% dividend yield. The last ex-dividend date was 2026-03-17. View full dividend history in the Dividends section.

What are the top holdings of IBB?

IBB's largest holdings are Amgen Inc (7.3%), Gilead Sciences, Inc (7.3%), Vertex Pharmaceuticals Incorporated (7.2%) (combined weight: 21.9%). The fund holds 257 total positions. View the complete portfolio breakdown in the Holdings section.

How does IBB compare to similar ETFs?

Compare IBB (0.44% expense ratio, $8.48B AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.